Pancreatic Malignancy, Pancreatic Neuroendocrine Tumor, Chronic Pancreatitis, Pancreatic Pseudocyst
Conditions
Interventions
Pancreatic Lesion Group:N/A
Normal Pancreas Group:N/A
Sponsors
Nanfang Hospital, Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Voluntarily sign the informed consent form; 2. Age >= 18 years; 3. Patients with various pancreatic diseases who are surgical candidates for pancreatic surgery.
Exclusion criteria
Exclusion criteria: 1. History of pancreatic plastic stent placement and drainage via endoscopic ultrasonography or percutaneous approach, or previous pancreatic duct stent implantation; 2. Presence of artificial implants, such as vascular stents, artificial grafts, etc.; 3. History of taking diagnostic or therapeutic drugs carried by nanomaterials; 4. History of cardiac surgery, arterial embolization, or hemodialysis; 5. Deemed ineligible for participation in this study as assessed by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Enrichment, abundance differences, and physical characteristics of target microplastic types in normal pancreatic tissues and various pathological tissues.; | — |
Secondary
| Measure | Time frame |
|---|---|
| The association between the enrichment and abundance differences of microplastics in pancreatic tissues and the categories of pancreatic lesions as well as the patients' history of plastic exposure.; | — |
Countries
China
Contacts
Public ContactWeiguang Qiao
Nanfang Hospital, Southern Medical University
Outcome results
None listed